Protein Therapy


Also found in: Wikipedia.

Protein Therapy

 

a method of treating diseases in man and animals by injecting protein parenterally, that is, not through the alimentary canal. The proteins are usually administered intramuscularly; they include one’s own blood (autohe-motherapy), the blood of a donor (isohemotherapy), and milk or a solution of casein, milk’s main protein (lactotherapy). Other proteins are also used, including serums and vaccines (serotherapy and vaccinotherapy). Serotherapy and vaccinotherapy are specific in the effect they produce, and the action of a preparation is aimed at the causative agent of a particular infection. All other types of protein therapy are nonspecific in nature and are aimed at increasing the body’s general resistance.

Various chronic and pathological diseases whose course is mild, for example, infectious processes, infectious and allergic processes, and trophic ulcers, are usually indications for protein therapy. Attempts have been made to use nonspecific vaccinotherapy in treating tumors and leukemia by the contemporary French scientist G. Maté.

The products of both autolysis and the decomposition of injected proteins are most important in protein therapy. Their stimulating effect on restoration processes in tissues is well known and is reflected in a series of old biological concepts, including G. Haberlandt’s wound hormones, A. Carrel’s tre-phons, and V. P. Filatov’s biogenic stimulants. Two factors are probably important in the mechanism of protein therapy. The first factor is that the products of protein decomposition activate the body’s own proteins, including those that are immunocompetent, on the basis of the feedback principle. The second factor is that the presence of a large quantity of low-molecular protein precursors in the tissue medium provides the plastic material required for biosynthesis.

The beneficial effect that protein therapy produces in the treatment of tumors is possibly related to the fact that all forms of protein therapy raise the level of normal regenerative processes and that antagonism exists between regeneration and development of the tumor (the Soviet biologist B. P. Tokin, 1940, 1959). This phenomenon was further investigated by Austrian researchers—F. Seilern-Aschpang and his colleagues (1960–63)—who showed that in invertebrates and some vertebrates, for instance, tritons, tumors rarely develop in parts of the body that are easily regenerated, such as the tail and extremities in the triton; when they do develop in such parts of the body, they generally heal by themselves. Involution of a tail tumor in a triton can be accelerated by amputating the healthy part of the organ, thereby triggering regeneration.

G. B. GOKHLERNER

Mentioned in ?
References in periodicals archive ?
The company said Alprolix is the first extended half-life and recombinant factor IX Fc fusion protein therapy approved for the treatment of haemophilia B in Saudi Arabia.
Ireland-based biopharmaceutical company Horizon Pharma plc (NASDAQ: HZNP) has agreed to acquire New York, US-based RV001 protein therapy teprotumumab medication provider River Vision Development Corp.
What they found was a combination of anthrax toxin protein therapy and chemo did just that.
Combining neural stem cell therapy with a protein therapy, in a single and permanent delivery, is a powerful new therapeutic modality.
ISLAMABAD -- Researchers from Stanford has created an "evolved" protein therapy that might stop cancer from spreading in body.
Scientists in Bristol have developed a system of tubes and catheters that allows them to pump protein therapy deep into patients' brains.
Develop ways to introduce new ribonucleic proteins into the body and remove those present through transplantation, cell therapy, somatic gene and protein therapy, and germ line gene therapy.
The biopharmaceutical company develops protein therapy products (derived from blood plasma) used to treat conditions such as immune deficiency disorders, severe burns, and hemophilia.
Those drugs include adalimumab (Humira) and infliximab (Remicade), but the authors also studied etanercept (Enbrel), a protein therapy medication, and other RA drugs for comparison.
Discovered and developed by Vical scientists, this patented gene-based treatment method delivers IL-2 locally within a tumor, and may provide similar benefits to systemic IL-2 protein therapy with fewer side effects.
If the microspheres prove as safe and effective in humans as in monkeys, people may soon be able to avoid the daily injections now required for most forms of protein therapy, says Putney.
Medgenics believes its Biopump platform offers an approach to protein therapy with multiple benefits compared with current treatments, which include regular and costly injections of therapeutic proteins.